The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrimorus Inv. Regulatory News (PRIM)

Share Price Information for Primorus Inv. (PRIM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.15
Bid: 3.80
Ask: 4.50
Change: 0.00 (0.00%)
Spread: 0.70 (18.421%)
Open: 4.15
High: 4.15
Low: 4.15
Prev. Close: 4.15
PRIM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment in Alteration Earth PLC

21 Oct 2021 07:00

RNS Number : 7420P
Primorus Investments PLC
21 October 2021
 

Primorus Investments plc

 

("Primorus" or the "Company")

 

Investment in Alteration Earth PLC

 

Primorus Investments plc (AIM: PRIM) is pleased to announce it has agreed to invest up to £350,000 in Alteration Earth PLC ("ALTE"), a recently established special purpose acquisition company ("SPAC") (the "Investment").

 

The Investment is being made in two parts, a seed round (the "Seed Round") and a subscription round (the "Subscription Round"). The Seed Round will be funded at 4p per ordinary share and the Subscription Round will be funded at 10p per ordinary share. Assuming both rounds are fully subscribed, Primorus will hold 5,000,000 ordinary shares as follows:

· 2,500,000 shares at 4p per share in the seed round (for a total of £100,000); and

· 2,500,000 shares at 10p per share in the subscription round (for a total of £250,000).

 

The Investment will represent an approximate ownership of 28% of the issued share capital of ALTE assuming both the Seed Round and Subscription Round are fully subscribed.

 

The Subscription Round is conditional on the admission of ALTE's share capital to the Standard Segment of the Main Market of the London Stock Exchange on or before 31 December 2021 ("Admission"). The subscription monies will be held in escrow on behalf of the investors until such time as Admission takes place, or will be returned to the investors if Admission does not take place before 31 December 2021.

 

In addition to the above, Primorus has been granted 1,800,000 warrants to subscribe for new ordinary shares in ALTE, with a strike price at par value (0.1p), at any time up to the fifth anniversary of the date of grant. The warrants have been awarded to Primorus because it has agreed to underwrite the cost, up to a maximum of £150,000, of ALTE obtaining Admission as described above.

 

If Admission does not occur by 31 December 2021, the Subscription Round will not proceed, and all Subscription Round funds delivered by Primorus pursuant to this agreement will be returned to it, without interest, less the costs incurred by ALTE pursuant to the listing up to a maximum of £150,000.

 

About ALTE

 

ALTE is seeking to list on the Standard Segment of the Main Market of the London Stock Exchange on or before 31 December 2021. ALTE has been created as SPAC with a focus on clean technology and clean energy investments.

 

ALTE has formed a partnership with the strategic and financial advisory firm Gneiss Energy (https://gneiss.energy/) to ensure it maximises its prospects of finding the most value-accretive acquisition for its shareholders. Gneiss has an extensive track record within the energy and clean technology sector. Gneiss has a dedicated team that specialises in mergers and acquisitions and this expertise will be leveraged to search for and recommend assets to ALTE. Gneiss will carry out the screening and detailed due diligence on the potential assets which will ensure a high level of professional due diligence is completed and in turn maximising the chances of ALTE acquiring a strong performing and commercially viable asset.

 

ALTE is seeking to raise a total of £1,260,000 for its proposed listing. This amount will be allocated as follows:

· 9,000,000 shares at 4p (Seed Round); and

· 9,000,000 shares at 10p (Subscription Round).

 

ALTE has stated that it will consider any investment that presents itself within the clean technology and/or clean energy sector; however, the management team will give priority to the following:

¡ Hydrogen production and technology

¡ Waste to energy

¡ Repurposing and recycling businesses and technology

¡ Infrastructure, construction and building technology

¡ Energy storage and deployment technology

¡ Renewable energy

 

Matthew Beardmore has joined the board of ALTE as a non-executive director for the purposes of monitoring the Primorus investment.

 

In addition to Primorus making its investment into ALTE, Matthew Beardmore, Rupert Labrum and Simon Holden have agreed to invest in ALTE as follows:

· Matthew Beardmore has agreed to invest £28,000 (approximately 2% of the issued share capital) based on 200,000 shares at 4p and 200,000 shares at 10p;

· Matthew Beardmore has also been awarded 450,000 warrants to subscribe for new ordinary shares with a strike price at par value (0.1p);

· Simon Holden has agreed to invest £28,000 (approximately 2% of the issued share capital) based on 200,000 shares at 4p and 200,000 shares at 10p; and

· Rupert Labrum has agreed to invest £252,000 (representing 20% of the issued share capital) based on 1,800,000 shares at 4p and 1,800,000 shares at 10p.

 

Related Party Transaction

 

 

Matthew Beardmore was one of two subscriber shareholders, and currently holds one of the two shares, in ALTE, and therefore the Investment is deemed under the AIM Rules for Companies to be a related party transaction. In addition, Simon Holden, company secretary of the Company, subscribed for the other founder share.

 

The independent directors, being Rupert Labrum and Hedley Clark, consider, having consulted with Cairn Financial Advisers LLP, the nominated adviser to the Company, that the terms of the Investment are fair and reasonable insofar as its shareholders are concerned.

 

 

Rupert Labrum, Executive Chairman of Primorus, commented: "We believe the opportunity to participate early in the evolution of ALTE and particularly in this area of the market represents a significant opportunity to add tangible value for Primorus shareholders. ALTE has targeted an area of the market that we believe is going to see exponential growth over the coming years as the world transitions into cleaner forms of energy."

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation.

 

 

For further information please contact:

 

Primorus Investments plc

Matthew Beardmore, Chief Executive Officer

 

+44 (0)20 8154 7907

 

Nominated Adviser

Cairn Financial Advisers LLP

Sandy Jamieson/James Caithie

 

+44 (0) 20 7213 0880

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFFSLIILIFIL
Date   Source Headline
2nd Nov 201811:00 amRNSPrice Monitoring Extension
24th Oct 20188:00 amRNSQuarterly Investor Update
16th Oct 20187:00 amRNSLoan Note Investment - Zuuse Pty Ltd
25th Sep 20187:00 amRNSCompletion of Disposal of Interest in HHDL to UKOG
10th Sep 201812:30 pmRNSHorse Hill Update
30th Aug 20188:00 amRNSDisposal of Interest in Horse Hill - Update
20th Aug 20187:00 amRNSDisposal of Interest in Horse Hill
3rd Aug 201811:30 amRNSHorse Hill Update
20th Jul 20187:00 amRNSHalf-year Report
18th Jul 20182:00 pmRNSHorse Hill Update
18th Jul 20187:00 amRNSQuarterly Investor Update
2nd Jul 20184:40 pmRNSSecond Price Monitoring Extn
2nd Jul 20184:35 pmRNSPrice Monitoring Extension
2nd Jul 20182:06 pmRNSSecond Price Monitoring Extn
2nd Jul 20182:00 pmRNSPrice Monitoring Extension
27th Jun 20187:00 amRNSHorse Hill Update
20th Jun 20183:01 pmRNSResult of AGM
14th Jun 201812:30 pmRNSHorse Hill Update
25th May 20187:00 amRNSPublication of Report & Accounts and Notice of AGM
18th May 20187:00 amRNSFinal Results
16th Apr 20183:59 pmRNSDirector/PDMR Shareholding
16th Apr 20187:25 amRNSQuarterly Update
23rd Mar 20187:00 amRNSHorse Hill Update
13th Mar 20187:00 amRNSInvestment in Engage Technology Partners Limited
9th Mar 20187:00 amRNSCompletion of Disposal of 5% of HHDL
2nd Mar 20184:02 pmRNSHolding(s) in Company
28th Feb 20187:00 amRNSDisposal of 5% of HHDL
12th Jan 20188:02 amRNSStream TV partners with BOE Technology
9th Jan 201810:09 amRNSGrant of Options
9th Jan 201810:09 amRNSGrant of Options
4th Jan 20187:00 amRNSQuarterly Investor Update
19th Dec 20177:00 amRNSHorse Hill Update
7th Dec 201710:29 amRNSDirector/PDMR Shareholding
6th Dec 20172:21 pmRNSHolding(s) in Company
6th Dec 20177:00 amRNSDirector/PDMR Shareholding
4th Dec 20177:00 amRNSSale of Gold Mines of Wales Investment
28th Nov 20177:00 amRNSSecond Round Investment in WeShop
23rd Nov 20177:00 amRNSIssue of Equity and Appointment of Broker
9th Nov 201712:23 pmRNSResult of AGM
8th Nov 20177:00 amRNSFresho Update and Further Investment
2nd Nov 20172:43 pmRNSDirector/PDMR Shareholding
30th Oct 20171:04 pmRNSDirector/PDMR Shareholding
27th Oct 201710:20 amRNSDirector/PDMR Shareholding
26th Oct 20177:00 amRNSDirector/PDMR Shareholding
25th Oct 20177:00 amRNSDirector/PDMR Shareholding
18th Oct 20173:45 pmRNSHorse Hill Update
16th Oct 20174:24 pmRNSNotice of AGM
4th Oct 201710:56 amRNSDirector/PDMR Shareholding
29th Sep 20179:48 amRNSDirector/PDMR Shareholding
27th Sep 20177:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.